title: Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice.
abstract: Urokinase-type plasminogen activator (uPA) is increased in human abdominal aortic aneurysm (AAA). Chronic infusion of angiotensin II (Ang II) results in AAA in apolipoprotein E-deficient mice. We tested the hypothesis that Ang II infusion results in an elevation of uPA expression contributing to aneurysm formation. Ang II or vehicle was infused by osmotic pumps into apoE-KO mice. All mice treated with Ang II developed a localized expansion of the suprarenal aorta (75% increase in outer diameter), accompanied by an elevation of blood pressure (22 mmHg), compared to the vehicle-treated group. Histological examination of the dilated aortic segment revealed similarities to human AAA including focal elastin fragmentation, macrophage infiltration, and intravascular hemorrhage. Ang II treatment resulted in a 13-fold increase in the expression of uPA mRNA in the AAA segment in contrast to a twofold increase in the atherosclerotic aortic arch. Increased uPA protein was detected in the abdominal aorta as early as 10 days after Ang II infusion before significant aorta expansion. Thus, Ang II infusion results in macrophage infiltration, increased uPA activity, and aneurysm formation in the abdominal aorta of apoE-KO mice. These data are consistent with a causal role for uPA in the pathogenesis of AAA.
authors.affiliation: Department of Pharmacology, Berlex Biosciences, Richmond, California, USA.
authors.forename: Y X
authors.initials: YX
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Martin-McNulty
authors.forename: A D
authors.initials: AD
authors.lastname: Freay
authors.forename: D A
authors.initials: DA
authors.lastname: Sukovich
authors.forename: M
authors.initials: M
authors.lastname: Halks-Miller
authors.forename: W W
authors.initials: WW
authors.lastname: Li
authors.forename: R
authors.initials: R
authors.lastname: Vergona
authors.forename: M E
authors.initials: ME
authors.lastname: Sullivan
authors.forename: J
authors.initials: J
authors.lastname: Morser
authors.forename: W P
authors.initials: WP
authors.lastname: Dole
authors.forename: G G
authors.initials: GG
authors.lastname: Deng
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D017544:Aortic Aneurysm, Abdominal / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D001057:Apolipoproteins E / Q000172:deficiency* / Q000235:genetics; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout / Q000235:genetics; D012016:Reference Values; D013997:Time Factors; D014463:Ultrasonography; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
chemical_list: D001057:Apolipoproteins E; D015850:Interleukin-6; D000804:Angiotensin II; D014568:Urokinase-Type Plasminogen Activator